The 2021 performance express and 2021 annual report disclosure of A-share listed companies are in full swing.
On the 3rd, Sichuan Hebang Biotechnology Co.Ltd(603077) disclosed that the performance express showed that the company’s profit increased significantly year-on-year, and the net profit soared by more than 70 times year-on-year, and the net profit attributable to the parent increased by nearly 7 times year-on-year.
In fact, Sichuan Hebang Biotechnology Co.Ltd(603077) is only one of the representatives of beautiful performance. Among the companies that disclosed the performance of 2021 that night (including performance express and annual report), the net profit of many companies doubled year-on-year.
From the performance disclosed so far, the companies with positive year-on-year performance growth in 2021 are the mainstream, accounting for more than 70%.
profits soared by more than 70 times year-on-year Sichuan Hebang Biotechnology Co.Ltd(603077) send performance express
the performance express released on Sichuan Hebang Biotechnology Co.Ltd(603077) 3 March shows that the company achieved an operating revenue of 9.867 billion yuan in 2021, an increase of 87.56% over the same period of the previous year; In 2021, the company realized a net profit attributable to the shareholders of the listed company of 3.023 billion yuan, a sharp increase of 728428% over the same period of the previous year; The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was about 3.015 billion yuan, an increase of 690.68% over the same period of last year.
As for the main reasons for the increase of the company’s operating performance in 2021, Sichuan Hebang Biotechnology Co.Ltd(603077) said that benefiting from the improvement of environmental protection requirements and the further clearing of backward production capacity caused by the epidemic, the limited expansion of production capacity and the growth of downstream demand, the company could drive up the sales price and obtain reasonable operating profit.
Sichuan Hebang Biotechnology Co.Ltd(603077) announced that in recent years, through combing the basic work, the company has made large-scale investment in environmental protection, safety and capacity matching, which has brought advantages in safety, environmental protection, cost control and stable operation, enabling the company to achieve high-yield and stable operation as planned, thus ensuring the steady improvement of sales.
In addition, Sichuan Hebang Biotechnology Co.Ltd(603077) also said that the company continued to cultivate corporate culture, improve employee literacy and recruit high-quality talents, so as to effectively improve the management efficiency and execution of the company, so as to ensure the high-quality operation of the company.
It is worth noting that with the substantial growth of performance, Sichuan Hebang Biotechnology Co.Ltd(603077) in the past 2021, the share price also rose sharply, with a cumulative increase of more than 140% in that year. Since 2022, Sichuan Hebang Biotechnology Co.Ltd(603077) share price has further increased by 14.37%.
However, in the process of rising share prices, important shareholders of the company also reduced their holdings. According to an announcement issued by Sichuan Hebang Biotechnology Co.Ltd(603077) 2022 in February, on February 16, 2022, the company received the notification of share reduction results sent by the shareholder Provincial Salt Corporation. As of February 16, 2022, the Provincial Salt Corporation reduced 176266764 shares of the company through centralized bidding trading, accounting for 1.9959% of the total share capital of the company. As of the disclosure date of the announcement at that time, the implementation of the reduction plan had been completed.
In addition, Sichuan Hebang Investment Group Co., Ltd. (hereinafter referred to as “Hebang group”), the major shareholder of Sichuan Hebang Biotechnology Co.Ltd(603077) , also reduced its holdings of Sichuan Hebang Biotechnology Co.Ltd(603077) .
multiple companies double profits
chemical, pharmaceutical and other industries with outstanding performance
In fact, in addition to Sichuan Hebang Biotechnology Co.Ltd(603077) , the performance of many companies doubled in 2021, and some companies even increased by more than 10 times.
For example, among the companies that disclosed the performance express on March 3, Hainan Mining Co.Ltd(601969) , Wuxi Nce Power Co.Ltd(605111) , Heilongjiang Publishing & Media Co.Ltd(605577) , China Coal Energy Company Limited(601898) and other companies also doubled their net profits year-on-year.
The total operating revenue of the company increased by 1.9 billion yuan over the same period of last year, showing a rapid growth of 49%; The net profit attributable to the shareholders of the listed company was 874 million yuan, an increase of 513.55% over the same period last year. By the end of the reporting period of the 2021 annual report, the total assets of the company were 10.899 billion yuan, an increase of 27.95% over the beginning of the period; At the end of the reporting period, the owner’s equity attributable to the parent company was 5.596 billion yuan, an increase of 40.24% over the beginning of the period.
As for the reasons for the substantial increase in performance, Hainan Mining Co.Ltd(601969) said that during the reporting period, the company actively grasped the favorable opportunity of the overall upward cycle of bulk commodities such as iron ore, oil and gas, timely paid attention to the market situation, adjusted the product structure, reasonably arranged the production plan, continuously improved the refined management level of the production system, and increased the sales price of products in a timely and appropriate manner, Realized the increase of the company’s sales revenue and profit in the current period. Meanwhile, ROC Oil Company Pty Limited, the holding subsidiary of the company, acquired 100% equity of ROC oil (Chengdu) Co., Ltd. (the company name before the acquisition was EOG resources China Limited) in May 2021, further improving the profitability of the company. In addition, the increase in the fair value of the company’s secondary market stock investment in the reporting period has made a certain contribution to the company’s profit growth.
Wuxi Nce Power Co.Ltd(605111) released the performance express, which showed that the company achieved a revenue of 1.498 billion yuan in 2021, with a year-on-year increase of 56.89%, and the net profit attributable to shareholders of listed companies was 410 million yuan, with a year-on-year increase of 194.55% Wuxi Nce Power Co.Ltd(605111) said that since 2021, the localization process of the company’s industry segments has accelerated, the prosperity has continued to rise, and the supply of products has fallen short of demand. Focusing on market demand, customer demand and industry development trend, the company actively carries out R & D upgrading and product technology iteration; Continuously develop and maintain supply chain resources to obtain more capacity support; At the same time, optimize the market structure, customer structure and product structure, quickly increase the sales scale and proportion of shielded grid power MOSFET, IGBT and other products, successfully develop emerging markets such as photovoltaic energy storage and new energy vehicles and their key customers, and achieve a large number of sales, so as to finally achieve a better growth of business scale and economic benefits.
According to the reporter’s statistics, if the companies that disclosed the 2021 performance express and the 2021 formal annual report are included, up to now, more than 900 companies have disclosed the 2021 performance, of which nearly 700 companies have a year-on-year increase in net profit and a positive year-on-year increase in performance, accounting for more than 70%.
Among them, the net profit of more than 140 companies doubled year-on-year. Observing the industries of the above 140 companies, we can find that there are many electronic, chemical, mechanical equipment, pharmaceutical and biological companies.
According to further statistics, up to now, there are many companies whose net profit has increased by more than 10 times year-on-year in 2021, including Nuode Investment Co.Ltd(600110) , Sichuan Hebang Biotechnology Co.Ltd(603077) , Guangdong Tonze Electric Co.Ltd(002759) , Chimin Health Management Co.Ltd(603222) , Beijing Hotgen Biotech Co.Ltd(688068) , Xinjiang Zhongtai Chenical Co.Ltd(002092) , Tianjin Lisheng Pharmaceutical Co.Ltd(002393) , Dongxin, etc. these companies are mainly in pharmaceutical, biological, chemical, electronic and other industries.
